Abstracts

THE COURSE OF NEUROCOGNITIVE PERFORMANCE OVER FOUR YEARS IN WELL-TREATED PLWH

Background: Among people living with HIV (PLWH) enrolled in the Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study, we have observed a neurocognitive impairment (NCI) prevalence of 40% by Frascati criteria. However, most patients have asymptomatic neurocognitive impairment (ANI), and analysed trajectories at two-years follow-up showed no signs of decline. In the current…

SIV CLEARANCE FROM NEONATAL MACAQUES FOLLOWING TRANSIENT CCR5 DEPLETION

Background: Treatment of people with HIV (PWH) with antiretroviral therapy (ART) results in sustained suppression of viremia, but due to virus that persists during ART, stopping treatment leads almost invariably to viral recrudescence and rebound viremia. This persistent virus, the “rebound competent viral reservoir” (RCVR), is the primary obstacle to more definitive treatment of HIV.…

PHARMACOKINETICS OF STANDARD VS DOUBLE-DOSE DOLUTEGRAVIR AFTER SWITCH FROM EFAVIRENZ

Background: Dolutegravir (DTG) is the preferred second-line antiretroviral backbone agent for people living with HIV (PLWH) failing a first-line efavirenz (EFV)-based regimen. EFV induces genes associated with the metabolism and transport of DTG. The resulting drug-drug interaction between EFV and DTG significantly reduces DTG’s exposure for up to 14 days when switching from an EFV-based…

RISK BEHAVIOUR TRAJECTORIES AMONG PEOPLE TREATED FOR RECENT HCV INFECTION

Background: There has been limited exploration of sexual and drug use behaviours following treatment for recent hepatitis C virus (HCV) infection (duration of infection < 12-months). This analysis modelled behavioural trajectories following treatment for recent HCV infection and assessed HCV reinfection and sexually transmitted infection (STI) incidence. Methods: Participants treated for recent HCV in the…

SIGLEC-9 RESTRAINS ANTIBODY-DEPENDENT NK CELL CYTOTOXICITY AGAINST SARS-CoV-2

Background: SARS‑CoV‑2 infection alters the immunological profiles of natural killer (NK) cells. However, whether NK anti-viral functions (direct cytotoxicity and/or antibody-dependent cell cytotoxicity (ADCC)) are impaired during severe COVID-19 and what host factors modulate these functions remain unclear. Methods: Using functional assays, we examined the ability of NK cells from SARS-CoV-2 negative controls (n=12), mild…